# Adjunct Episcleral Brachytherapy for PCV

> **NCT05251636** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Salutaris Medical Devices, Inc.** · enrollment: 159 (estimated)

## Conditions studied

- Age-Related Macular Degeneration
- Polypoid Choroidal Vasculopathy

## Interventions

- **RADIATION:** Episcleral Brachytherapy
- **DRUG:** Aflibercept Injection

## Key facts

- **NCT ID:** NCT05251636
- **Lead sponsor:** Salutaris Medical Devices, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03
- **Primary completion:** 2026-09
- **Final completion:** 2028-09
- **Target enrollment:** 159 (ESTIMATED)
- **Last updated:** 2023-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05251636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05251636, "Adjunct Episcleral Brachytherapy for PCV". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT05251636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*